NINEMETERS BIOPHARMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Mar 2023)
What this means for you
This application is over — abandoned 27 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88573422
- Mark type
- Stylized text
- Filed
- 09 Aug 2019
- Published for opposition
- 24 Dec 2019
- Abandoned
- 27 Mar 2023
- Attorney of record
- Devon E. White
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form namely, gels, ointments and pastes, suppositories, in liquid form namely, drops, injectables, infusions, in gaseous form namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Suppositories with proprietary delivery system for the precise delivery of drugs that target conditions and diseases of the anorectal region; Suppositories
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; Medical and scientific research information in the field of novel pharmaceutical discovery and development; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of novel pharmaceutical treatments and clinical trials; Providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; Clinical trials services for others
Owner
- 9 METERS BIOPHARMA, RALEIGH, NC, US
- RDD Pharma, Inc., New York, NY, US
- RDD Pharma, Inc., New York, NY, US
Prosecution history
- 27 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2022 — SOU EXTENSION 5 GRANTED
- 04 Aug 2022 — SOU EXTENSION 5 FILED
- 12 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2022 — SOU EXTENSION 4 GRANTED
- 11 Feb 2022 — SOU EXTENSION 4 FILED
- 11 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Dec 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2021 — SOU EXTENSION 3 GRANTED
- 18 Aug 2021 — SOU EXTENSION 3 FILED